on OXURION (EBR:OXUR)
Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting
Leuven, Belgium – April 11, 2025 – Oxurion NV, a company listed on Euronext Brussels under the symbol OXUR, specializing in the development of ophthalmic therapies, has published its annual report for the financial year ending December 31, 2024. This document is available in the "Investors" section of the company's website and can be downloaded in PDF format.
In addition, Oxurion has convened its Annual General Meeting of Shareholders. Documents relating to this meeting are available on the company's website, in the "Shareholders' Meetings" section.
Oxurion cautions against forward-looking statements included in this press release, which involve risks and uncertainties. The company assumes no obligation to update these statements in light of new information or future events.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news